Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation

NCT01656135 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT01656135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01656135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Lead sponsor
University of Regensburg
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2015
Enrollment
70 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal failure, kidney graft rejection